Weekly pill aims to shrink waistlines in new weight loss trial
NCT ID NCT07281937
Summary
This study is testing whether a new weekly oral pill called VRB-101 helps people lose weight compared to a placebo. It involves about 206 adults who have obesity or are overweight with other related health conditions. Participants take the pill or a placebo for 20 weeks to see which is more effective for weight loss and to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Study Site 101
Rochester, New York, 14609, United States
-
Clinical Study Site 102
San Antonio, Texas, 78229, United States
-
Clinical Study Site 103
Anniston, Alabama, 36207, United States
-
Clinical Study Site 104
San Antonio, Texas, 78240, United States
-
Clinical Study Site 105
Norman, Oklahoma, 73069, United States
-
Clinical Study Site 106
Wichita, Kansas, 67207, United States
-
Clinical Study Site 107
Montclair, California, 91763, United States
-
Clinical Study Site 108
Monroe, North Carolina, 28112, United States
-
Clinical Study Site 109
Cullman, Alabama, 35055, United States
-
Clinical Study Site 110
Phoenix, Arizona, 85028, United States
-
Clinical Study Site 111
Anaheim, California, 92801, United States
-
Clinical Study Site 112
Dallas, Texas, 75251, United States
-
Clinical Study Site 113
Little Rock, Arkansas, 72205, United States
-
Clinical Study Site 114
Duncansville, Pennsylvania, 16635, United States
-
Clinical Study Site 115
Knoxville, Tennessee, 37909, United States
-
Clinical Study Site 116
West Des Moines, Iowa, 50266, United States
-
Clinical Study Site 117
Binghamton, New York, 13905, United States
-
Clinical Study Site 118
Tarzana, California, 91356, United States
-
Clinical Study Site 119
Decatur, Georgia, 30030, United States
-
Clinical Study Site 120
Charlotte, North Carolina, 28210, United States
-
Clinical Study Site 121
Omaha, Nebraska, 68134, United States
-
Clinical Study Site 122
Southfield, Michigan, 48076, United States
Conditions
Explore the condition pages connected to this study.